🚀 VC round data is live in beta, check it out!
Uniphar Valuation Multiples
Discover revenue and EBITDA valuation multiples for Uniphar and similar public comparables like Alvotech, Cohance Lifesciences, GNI Group, Dicker Data and more.
Uniphar Overview
About Uniphar
Uniphar PLC is a diversified healthcare service organization with activities in Ireland, the UK, and the Benelux. The business activities of the group function through the Commercial & Clinical division, which provides outsourced services, specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers, and distribution and support services to medical device manufacturers. The product Access division consists of two service offerings, being: On-Demand Access and Exclusive Access. Supply Chain and Retail division provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland.
Founded
1994
HQ
Employees
3.5K
Website
Financials (LTM)
EV
$2B
Uniphar Financials
Uniphar reported last 12-month revenue of $4B and EBITDA of $161M.
In the same LTM period, Uniphar generated $594M in gross profit, $161M in EBITDA, and $68M in net income.
Uniphar P&L
In the most recent fiscal year, Uniphar reported revenue of $4B and EBITDA of $158M.
Uniphar expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | XXX | $4B | XXX | XXX | XXX |
| Gross Profit | $594M | XXX | $529M | XXX | XXX | XXX |
| Gross Margin | 16% | XXX | 14% | XXX | XXX | XXX |
| EBITDA | $161M | XXX | $158M | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $68M | XXX | $68M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $198M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Uniphar Stock Performance
Uniphar has current market cap of $1B, and enterprise value of $2B.
Uniphar's stock price is $4.77.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | 0.1% | XXX | XXX | XXX | $0.26 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialUniphar Valuation Multiples
Uniphar trades at 0.4x EV/Revenue multiple, and 10.0x EV/EBITDA.
Uniphar Financial Valuation Multiples
As of March 29, 2026, Uniphar has market cap of $1B and EV of $2B.
Equity research analysts estimate Uniphar's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Uniphar has a P/E ratio of 18.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 10.0x | XXX | 10.2x | XXX | XXX | XXX |
| EV/EBIT | 14.9x | XXX | 15.1x | XXX | XXX | XXX |
| EV/Gross Profit | 2.7x | XXX | 3.1x | XXX | XXX | XXX |
| P/E | 18.3x | XXX | 18.1x | XXX | XXX | XXX |
| EV/FCF | 33.7x | XXX | 21.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Uniphar Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Uniphar Margins & Growth Rates
Uniphar's revenue in the last 12 month grew by 2%.
Uniphar's revenue per employee in the last FY averaged $1.1M.
Uniphar's rule of 40 is 7% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Uniphar's rule of X is 10% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Uniphar Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 7% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 10% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 9% | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Uniphar Public Comps
See public comps and valuation multiples for other Wholesale Distribution and Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Alvotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Cohance Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| GNI Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Dicker Data | XXX | XXX | XXX | XXX | XXX | XXX |
| Septerna | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Uniphar M&A Activity
Uniphar acquired XXX companies to date.
Last acquisition by Uniphar was on XXXXXXXX, XXXXX. Uniphar acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Uniphar
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialUniphar Investment Activity
Uniphar invested in XXX companies to date.
Uniphar made its latest investment on XXXXXXXX, XXXXX. Uniphar invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Uniphar
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Uniphar
| When was Uniphar founded? | Uniphar was founded in 1994. |
| Where is Uniphar headquartered? | Uniphar is headquartered in Ireland. |
| How many employees does Uniphar have? | As of today, Uniphar has over 3K employees. |
| Is Uniphar publicly listed? | Yes, Uniphar is a public company listed on Euronext Dublin. |
| What is the stock symbol of Uniphar? | Uniphar trades under UPR ticker. |
| When did Uniphar go public? | Uniphar went public in 2019. |
| Who are competitors of Uniphar? | Uniphar main competitors are Alvotech, Cohance Lifesciences, GNI Group, Dicker Data. |
| What is the current market cap of Uniphar? | Uniphar's current market cap is $1B. |
| What is the current revenue of Uniphar? | Uniphar's last 12 months revenue is $4B. |
| What is the current revenue growth of Uniphar? | Uniphar revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Uniphar? | Current revenue multiple of Uniphar is 0.4x. |
| Is Uniphar profitable? | Yes, Uniphar is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Uniphar? | Uniphar's last 12 months EBITDA is $161M. |
| What is Uniphar's EBITDA margin? | Uniphar's last 12 months EBITDA margin is 4%. |
| What is the current EV/EBITDA multiple of Uniphar? | Current EBITDA multiple of Uniphar is 10.0x. |
| What is the current FCF of Uniphar? | Uniphar's last 12 months FCF is $48M. |
| What is Uniphar's FCF margin? | Uniphar's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Uniphar? | Current FCF multiple of Uniphar is 33.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.